OsteoporosisGood! Romosuzumab is a humanized monoclonal antibody that binds to and inhibits sclerostin. By neutralizing sclerostin, romosuzumab exerts a dual effect on bone metabolism:
|
Map: A patient with Urothelial cancer (1038)
|
||
Review your pathway |